XNYS
LH
Market cap25bUSD
Oct 09, Last price
312.15USD
1D
0.71%
1Q
13.51%
Jan 2017
184.88%
Name
Laboratory Corporation of America Holdings
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Labcorp Holdings, Inc. delivers specialized diagnostic laboratory services. Its purpose is to empower a diverse group of stakeholders – including medical professionals, hospitals, pharmaceutical companies, scientific researchers, and individual patients – to arrive at well-informed and confident decisions. The organization commenced operations on April 16, 2024, and conducts its central management from its headquarters in Burlington, North Carolina.
Related entities
Subsidiaries (10)
CHILTERN INTERNATIONAL LIMITED
CLEARSTONE HOLDINGS (INTERNATIONAL) LTD
Dynacare Company
FORTREA DEVELOPMENT LIMITED
Labcorp Central Laboratory Services GmbH
LABCORP CLINICAL RESEARCH UNIT LIMITED
LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED
Labcorp International Holdings B.V.
LABCORP INTERNATIONAL HOLDINGS LIMITED
COVANCE LIMITED
Legal address
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
WILMINGTON, DE 19808
US
Headquarters
2626 Glenwood Avenue, Suite 550
Raleigh, NC 27608
US
Raleigh, NC 27608
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||